Keyword: The Bill & Melinda Gates Foundation

Vir Biotechnology

Vir Biotechnology focuses on developing vaccines and drugs to cure infectious diseases for which there are currently scarce treatments. Though it hasn’t provided any details about its pipeline quite yet, its launch was remarkable for the sheer size of the funding: $150 million from ARCH Venture Partners.